Diisopropyl malonate | CAS:13195-64-7

We serve Diisopropyl malonate CAS:13195-64-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Diisopropyl malonate

CAS No: 13195-64-7
Product Name: Diisopropyl malonate
Other Name:
Diisopropyl malonate
Malonic acid diisopropyl ester
Dipropan-2-yl propanedioate
 
Density: 1.0±0.1 g/cm3
Boiling Point: 207.0±8.0 °C at 760 mmHg
Molecular Formula: C9H16O4
Molecular Weight: 188.221
Flash Point: 89.4±16.9 °C
Exact Mass: 188.104858
PSA: 52.60000
LogP: 1.40
Vapour Pressure: 0.2±0.4 mmHg at 25°C
Index of Refraction: 1.425
 
Specification
Appearance: Colorless Transparent Liquid
Assay: ≥99.0%
Water: ≤0.05%
Acidity: ≤0.07%
 
Application
Intermediates of Isoprothiolane CAS: 50512-35-1.
Be used as pesticide intermediate, mainly used in the synthesis of the fungicide Isoprothiolane.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like Diisopropyl malonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dipropan-2-yl propanedioate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Diisopropyl malonate Use and application,Diisopropyl malonate technical grade,usp/ep/jp grade.


Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.10-bromobenzo[b]naphtho[1,2-d]furan manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).S-methyl butanethioate supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).4-nitrophenol vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).When a new strain emerges that has not yet been identified, as is the case with the current outbreak in China, it temporarily becomes known as a novel coronavirus (nCoV).